These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12230384)

  • 61. Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement.
    Nordin C
    Ann Intern Med; 2011 Aug; 155(4):276; author reply 276-7. PubMed ID: 21844561
    [No Abstract]   [Full Text] [Related]  

  • 62. Bone-density measurement.
    Sheldon T; Long A; Freemantle N; Pollock C
    Lancet; 1992 Feb; 339(8790):425. PubMed ID: 1346678
    [No Abstract]   [Full Text] [Related]  

  • 63. [Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé].
    Hiligsmann M; Bruyère O; Pire G; Reginster JY
    Rev Med Liege; 2008 Oct; 63(10):588-94. PubMed ID: 19009966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of clinical assessment in the prevention of osteoporotic fractures.
    Hough S
    S Afr Med J; 2000 Nov; 90(11):1109-11. PubMed ID: 11196028
    [No Abstract]   [Full Text] [Related]  

  • 65. [Current approaches to the diagnosis and treatment of postmenopausal osteoporosis].
    Baranova IA
    Ter Arkh; 2009; 81(10):56-60. PubMed ID: 19947443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
    Bone HG; Santora AC; Chattopadhyay A; Liberman U
    J Bone Miner Res; 2005 Nov; 20(11):2064-5. PubMed ID: 16234982
    [No Abstract]   [Full Text] [Related]  

  • 67. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 68. [Menopause and bone].
    Lobersztajn A; Trémollières F
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F28-32. PubMed ID: 23036315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Osteoporosis prevention and the orthopaedic surgeon: when fracture care is not enough.
    Fithian DC; Page AE
    J Bone Joint Surg Am; 1999 Nov; 81(11):1653-4. PubMed ID: 10565655
    [No Abstract]   [Full Text] [Related]  

  • 70. Treatment considerations in the management of age-related osteoporosis.
    Rubin CD
    Am J Med Sci; 1999 Sep; 318(3):158-70. PubMed ID: 10487406
    [No Abstract]   [Full Text] [Related]  

  • 71. Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings.
    Powell H; O'Connor K; Greenberg D
    J Womens Health (Larchmt); 2012 Jan; 21(1):50-3. PubMed ID: 22150154
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of osteoporosis in women aged 50 and older with osteoporosis-related fractures in a managed care population.
    Gunter MJ; Beaton SJ; Brenneman SK; Chen YT; Abbott TA; Gleeson JM
    Dis Manag; 2003; 6(2):83-91. PubMed ID: 14577902
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of osteoporosis.
    Miller PD
    Adv Intern Med; 1999; 44():175-207. PubMed ID: 9929709
    [No Abstract]   [Full Text] [Related]  

  • 74. Osteoporosis: screening and treatment in women.
    Pollycove R; Simon JA
    Clin Obstet Gynecol; 2012 Sep; 55(3):681-91. PubMed ID: 22828100
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone mineral density testing: is a T score enough to determine the screening interval?
    Doshi KB; Khan LZ; Williams SE; Licata AA
    Cleve Clin J Med; 2013 Apr; 80(4):234-9. PubMed ID: 23547094
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prevention of osteoporotic fractures].
    Kannus P
    Duodecim; 1999; 115(7):759-64. PubMed ID: 11859509
    [No Abstract]   [Full Text] [Related]  

  • 77. Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women.
    Nagata-Kobayashi S; Shimbo T; Fukui T
    J Bone Miner Metab; 2002; 20(6):350-7. PubMed ID: 12434163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
    Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention.
    McConaha JL; Berdine HJ; Skomo ML; Laux RV; Higginbotham SK; O'Neil CK
    J Pharm Pract; 2014 Feb; 27(1):25-30. PubMed ID: 24108433
    [TBL] [Abstract][Full Text] [Related]  

  • 80. True osteoporosis and frailty-related osteopenia: two different clinical entities.
    Russo CR; Ricca M; Ferrucci L
    J Am Geriatr Soc; 2000 Dec; 48(12):1738-9. PubMed ID: 11129773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.